Microbiology 3 Flashcards
Describe the viral replication cycle
- Virus binds to cell via receptor, enters cell (e.g. via endosome)
- Initiates reverse transcription
- cDNA produced, inserted into chromosome
- cDNA produces RNA strands via transcription of host chromosome
- RNA exits nucleus to produce viral proteins
- Assembled and released as new virus
What stages of the viral replication cycle can be targeted by drugs?
- Every stage
- Entry
- Uncoating
- Replication
- Release
- Immune Response
Give the 3 classes of antiviral therapy
- Drugs which target viral proteins (safe) e.g. inhibit viral replicative enzyme
- Drugs which target host proteins e.g. block receptors
- Drugs which enhance host defences e.g. interferons
What is meant by antiviral selectivity?
The difference between the dose of the drug which inhibits viral protein over any similar cellular protein
Which class of antiviral has the highest specificity?
Drugs targeting viral proteins that have no host analogues, may have absolute specificity. very safe
What are the targets to inhibit attachment and entry be inhibited?
- Viral proteins
- Host cell receptors
Give an example of a antiviral that inhibits viral uncoating
- Influenza A: hydrogen ions cause HA to fuse with membrane, and ions enter virion via M2 channels stimulating release of the nucleoprotein from the virus core
- Amantidine blocks M2, preventing influx of H+ and thus inhibiting release of nucleoproteins
How may viral genome replication be inhibited by antiviral drugs?
- Inhibition of viral polymerase (e.g. herpesvirus DNA polymerase, retrovirus reverse transcriptase)
- Nucleotide analogues
- Antiretroviral drugs
- Integrase inhibitors (HIV)
Explain how nucleotide analogies can inhibit genome replication
- Typically need to be activated by cellular or viral enzymes
- Nucleotide analogue incorporation prevents elongation of DNA and no functioning DNA produced
- e.g. acyclovir (herpesviridae), zidovudine (HIV)
Explain how antiretroviral drugs inhibit genome replication
- Non-nucleotide reverse transcriptase (RT) inhibitors e.g. nevirapine
- Bind near catalytic site of RT
- highly specific
Explain the mechanism of action of integrase inhibitors for HIV
- Bind to viral integrase to prevent viral cDNA from being inserted into the host genome
Describe the mechanism of action of protease inhibitors
- Inhibit virus assembly
- If viral proteins are produced as polyproteins and require cleavage this is a good drug target
- Immature (uncleaved) viruses are inactive
- e.g. HIV, hepatitis C in man
Describe the mechanism of action of antivirals that inhibit viral release
- e.g. Neuraminidase inhibitors
- Prevent release of influenza virus from cells
- Haemaglutinin (binds to sialic acids) important for getting virus into the cell
- Neuraminidase destroys sialic acids on cell allow release of virus
- Neuraminidase inhibitors prevent this destruction and so the virus cannot escape
Outline the use of antivirals in veterinary medicine
- Generally not done in farm/food production animals, often have secondary bacterial infections, expensive, MRLs a concern
- Few antivirals licensed in veterinary species, vaccines are main method
- Biosecurity important for production animals
- Treatment typically requires supportive therapy
Outline antiviral therapy in cats
- Feline interferon omega, nucleotide analogues, human interferon alpha used to treat FeLV and FIV
- Lymphocyte T cell immunomodulator for FeLV (USDA approved but not licensed in UK
- Feline interferon omega for FIP
- trifluorothymidine can be used to treat FIP, also acyclovir ointment, oral acyclovir, oral famicyclovir, L-lysine but these have little proof
List some problems with antiviral therapy
- Drug resistance due to fast development of viral mutants
- More of a worry in RNA viruses due to inherently higher mutation rate
Outline the use of multidrug antiviral therapy
- Combining drugs improves antiviral effect
- But increases complexity and cost, reduces compliance
What are superficial mycoses?
Fungal infections of the skin, hair and nails, mucosal surfaces in upper respiratory tract
What are subcutaneous mycoses?
Fungal infections affecting muscle and connective tissue, below the skin
What are systemic (invasive) mycoses?
Fungal infections of internal organs, may be primary or opportunistic and often relate to immune suppression or other issues
What are some challenges of antifungal therapy?
- Low susceptibility/high resistance
- Time take for drugs to show effect
- Environmental fomites leading to reinfection or cross infection
- Specificity issues/side effects
- Lack of vaccine
List the main groups of antifungal agents
- Polyenes
- Allylamines
- Azoles
- Echinocandins
- Pyrimidine analogues
- Antimitotics
What is the mechanism of action of polyenes?
- Bind to and disrupt fungal membranes
- Preferentially bind to ergosterol
- Binding alters membrane osmotic regulation, leads to leakage of intracellular potassium and other small molecules
Describe the structure of polyenes
- Composed of hydrophilic polyhydroxyl chain on one side
- Lipophilic polyene hydrocarbon chain on the other
Name some examples of polyenes and their use
- Amphotericin B: systemic infections
- Nystatin: topical and oral (mucosa and GI superficial infections)
What is the main limitation of polyenes?
Toxicity
Describe the formulation of most polyenes
- Poorly soluble in water
- Most formulations are lipid based, reduces intrinsic toxicity of compound
What is the mechanism of action of azoles?
- Interferes with ergosterol synthesis (membrane sterols)
- Fungistatic
- Inhibit 14-alpha-demethylase which depletes ergosterol over time, causes accumulation of methyl-ergostadiene-diol
- Methyl-ergostadiene-diol is toxic
What are the 2 groups of azoles?
- Imidazoles (ketoconazole, clotrimazole)
- Triazoles (Fluconazole, intraconazole)
Describe the rate of action of azoles
Slow, require several generations to act
What fungi are affected by azoles?
- Dimorphic
- dermatophytes
- Aspergillus only susceptible to triazoles, not other azoles
Describe the mechanism of action of allylamines
- Inhibit squalene epoxidase to reduce ergosterol production
- Interfere with ergosterol synthesis (membrane sterols)
- Accumulation of toxis squalene
Describe the spectrum of activity of allylamines
- Broad
- Especially active against dermatophytes
Name some allylamines
Terbinafine, butenafine
Describe the mechanism of action of echinocandins
- Inhibit glycan synthesis
- Affect hyphae growing tips and branching points
- Affect yeasts so that buds fail to separate from mother cell
- Also lead to osmotically sensitive fungal cells
Name examples of echinocandins
- Capsofungin
- Micafungin
- Anidulafungin
Outline resistance to echinocandins
- Intrinsic resistance in some fungal genera/species where other glycans predominate
Describe the mechanism of action of antimitotic antifungals
- Binds to tubulin and interferes with microtubule function
- Thus inhibits mitosis
Name an antimitotic antifungal
Griseofulvin
Describe the administration and distribution of griseofulvin
- Oral dose only, topically inactive
- Drug reaches site of action only when hair or skin replaced by keratin-griseofulvin complex